BAQSIMI
BAQSIMI
Approved
DIN Number
02492415
Drug Class
Human
Market Date
Nov 20, 2019
Company
HC
Amphastar Pharmaceuticals
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02492415
AIG Number0101772002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
H04AA01 GLUCAGON
Product Specifications
Dosage FormPowder
Route of AdministrationNasal
AHFS Classification68:22.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
GLUCAGONActive
Strength: 3 MG / CONTAINER
Monograph: GLUCAGON